Mesoblast Limited is a biotechnology company developing regenerative medicine therapies, focusing on stem cell treatments for inflammatory diseases and immune-related conditions.
Ticker code: MSB
Sector: Healthcare | Industry: Biotechnology | Website: https://www.mesoblast.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $3,617,876,045 | $3,584,482,037 | 1282934798 | 66.3 | $2,398,826,973 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $902,305,058 | $161,551,008 | $128,157,000 | -8.0 | -398.3 | -3.7 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Positive | 10.4 | $11,551,298 | $13,732,322 | 6.55 | 17.3 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $2.820 | 3.3 | 9.3 | 23.1 | 33.0 | 60.7 | 65.9 |
MSB Price Chart with Volume and 3EMA
MSB Short Positions
Click HERE to understand why the above moving averages have been chosen.